Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 2321 Neoplasms 1683 Prostatic Neoplasms 1180 Lung Neoplasms 911 Colorectal Neoplasms 876 Carcinoma, Non-Small-Cell Lung 851 Leukemia, Myeloid, Acute 587 Pancreatic Neoplasms 568 Multiple Myeloma 542 Carcinoma, Hepatocellular 511 Brain Neoplasms 510 Neoplasm Metastasis 457 Head and Neck Neoplasms 454 Melanoma 410 Ovarian Neoplasms 404 Glioblastoma 398 Precursor Cell Lymphoblastic Leukemia-Lymphoma 390 Stomach Neoplasms 370 Uterine Cervical Neoplasms 357 Squamous Cell Carcinoma of Head and Neck 357 Rectal Neoplasms 337 Recurrence 332 Hematologic Neoplasms 324 Sarcoma 322 Colonic Neoplasms 317 Lymphoma 311 Triple Negative Breast Neoplasms 284 Urinary Bladder Neoplasms 279 Carcinoma, Renal Cell 279 Glioma 278

Interventions

Neoadjuvant Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × High-Risk Cancer × 1 year × Clear all

NCT03978663 2026-02-20

TRIO

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase NA Active not recruiting

High-Risk Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡